1. | | Recruiting | Androgen Effects in HIV-infected Women Conditions: HIV Infection; HIV Wasting Syndrome |
2. | | Not yet recruiting | Evaluating Switching HIV Subject's Current Protease Inhibitor Therapies For A Fosamprenavir Therapy, Over 48 Weeks Condition: HIV Infections |
3. | | Not yet recruiting | Short-Term Study Of A Once-Daily Fixed-Dose Combination Tablet In Antiretroviral-Naive HIV-1 Infected Subjects. Condition: HIV Infections |
4. | | Not yet recruiting | HIV Assessment in Fuyang, Anhui Province, China Condition: HIV Infections |
5. | | Not yet recruiting | Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings Conditions: HIV Infections; Tuberculosis |
6. | | Recruiting | Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects Condition: HIV Infection |
7. | | Recruiting | Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents Conditions: HIV Infections; Influenza |
8. | | Not yet recruiting | Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052 Condition: HIV Infections |
9. | | Not yet recruiting | Nine Month Course of Anti-HIV Medications for People Recently Infected with HIV Condition: HIV Infections |
10. | | Recruiting | Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression Conditions: HIV Infections; Diabetes; Depression |
11. | | Recruiting | Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-experienced HIV1 Infected Adults Condition: HIV Infections |
12. | | Recruiting | TNX-355 with Optimized Background Therapy (OBT) in Treatment-Experienced Subjects with HIV-1 Condition: HIV Infections |
13. | | Recruiting | 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection Condition: HIV Infections |
14. | | Not yet recruiting | Optimal Treatment for Kidney Disease in HIV Infected Adults Conditions: HIV Infections; Kidney Disease |
15. | | Not yet recruiting | NNRTI- Versus PI-Containing Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child Transmission of HIV Condition: HIV Infections |
16. | | Recruiting | A phase II open-label, randomized, active-controlled study comparing the efficacy and safety of once daily Fuzeon (enfuvirtide) dosing versus the currently recommended twice daily dosing in HIV-1 infected treatment experienced patients. Condition: HIV Disease |
17. | | Not yet recruiting | Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients Condition: HIV Infections |
18. | | Recruiting | Effect of Tenofovir DF on Bone Metabolism in Children Condition: HIV Infections |
19. | | Recruiting | Blood Levels of Abacavir in HIV Infected Adolescents Condition: HIV Infections |
20. | | Not yet recruiting | Three Month Course of Anti-HIV Medications for People Recently Infected with HIV Condition: HIV Infections |
21. | | Recruiting | Long-term Follow-up of HIV Infected Patients Identified During Early Infection Condition: HIV Infections |
22. | | Recruiting | Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV Condition: HIV Infections |
23. | | Recruiting | HIV Study Of GW433908 Versus Kaletra, Both With Abacavir/lamivudine In Therapy-Naive Patients Condition: HIV Infections |
24. | | Recruiting | Peginterferon alpha-2a and ribavirin to treat hepatitis C in HIV-infected patients Conditions: Hepatitis C; HIV Infections |
25. | | Recruiting | Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy Conditions: HIV Infections; Peripheral Nervous System Diseases; Pain |
26. | | Recruiting | Safety of and Immune Response to Cyclosporine A in Combination with Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults with Acute HIV Infection Condition: HIV Infections |
27. | | Not yet recruiting | Once-Daily PI/NNRTI Therapy Combinations for Treatment Naive, HIV Infected Patients in Resource-limited Conditions Condition: HIV Infections |
28. | | Recruiting | Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV Condition: HIV Infections |
29. | | Not yet recruiting | Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission Condition: HIV Infections |
30. | | Not yet recruiting | Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV Condition: HIV Infections |
31. | | Recruiting | Atazanavir/Ritonavir Maintenance Therapy Condition: HIV Infections |
32. | | Not yet recruiting | Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults Condition: HIV Infections |
33. | | Recruiting | Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers Conditions: Healthy; HIV Infections |
34. | | Recruiting | Treatment of Abnormal Adipose Tissue Accumulation in HIV Patients Conditions: HIV Infections; Lipodystrophy |
35. | | Recruiting | Safety and Effectiveness of the Oral HIV Entry Inhibitor SCH 417690 in HIV Infected Patients Condition: HIV Infections |
36. | | Recruiting | A Clinical Research Study Of FDA-Approved HIV Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy Condition: HIV Infections |
37. | | Recruiting | Roll-over Trial Only for HIV-1 Infected Subjects in Selected TMC114 Trials who Fail Treatment Condition: HIV Infections |
38. | | Not yet recruiting | Strategies for Delivering Anti-HIV Therapy in South Africa Condition: HIV Infections |
39. | | Recruiting | Daclizumab to Treat HIV-Infected Patients Condition: HIV Infections |
40. | | Not yet recruiting | Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers with HIV Conditions: HIV Infections; Tuberculosis; Pneumocystis carinii Pneumonia |
41. | | Recruiting | Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients Condition: HIV Infections |
42. | | Recruiting | L-Carnitine to Treat Fatigue in AIDS Patients Conditions: HIV Infections; AIDS |
43. | | Recruiting | Comparing the Effects of Smoked and Oral Marijuana in Individuals with HIV/AIDS Condition: HIV Infections |
44. | | Recruiting | Steps to Maximize Adherence to Anti-Retroviral Treatment (SMAART) Condition: HIV Infections |
45. | | Not yet recruiting | Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People Condition: HIV Infections |
46. | | Recruiting | Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) Conditions: HIV Infections; Hepatitis C; Liver Disease |
47. | | Recruiting | Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis Conditions: HIV Infections; Tuberculosis |
48. | | Not yet recruiting | Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia Conditions: HIV Infections; HIV Seronegativity |
49. | | Recruiting | Tipranavir in Combination with Ritonavir in HIV-Infected Children Condition: HIV Infections |
50. | | Recruiting | Safety of the EnvPro HIV Vaccine in Healthy Volunteers Condition: HIV Infections |